Anthropic has rapidly expanded its footprint in healthcare this year, rolling out a HIPAA-compliant AI platform for providers, investing in drug discovery and public health initiatives, advancing cybersecurity programs aimed at protecting critical infrastructure and weighing in on the future of AI regulation.
Here are six of the company’s biggest healthcare moves so far in 2026, as reported by Becker’s:
- At June 30 event in San Francisco, Eric Kauderer-Abrams, Anthropic’s life sciences head, said Anthropic is launching an internal drug discovery program with a focus on neglected diseases that traditional pharmaceutical companies would not consider commercially attractive.
- On June 10, Anthropic published two policy frameworks calling for stronger federal oversight of advanced AI systems, including mandatory safety testing, independent evaluations and penalties for companies that violate safety requirements. The company highlighted cybersecurity threats to critical infrastructure, including hospitals, as a key risk area and urged investments in more secure software and modernization of legacy systems. Anthropic also opposed federal preemption of state AI laws unless national regulations meet or exceed the standards outlined in its proposals.
- On June 9, Anthropic launched Claude Fable 5 and Claude Mythos 5, a new class of AI models the company says accelerated parts of its internal drug design work by about 10 times. Anthropic reported the models demonstrated advanced capabilities in drug discovery, protein engineering and genomics, including generating novel scientific hypotheses and autonomously completing complex biology research tasks. While Fable 5 is available broadly, the more powerful Mythos 5 is currently limited to select partners and researchers.
- On June 2, Anthropic expanded Project Glasswing, adding 150 organizations to its initiative aimed at identifying and remediating critical software vulnerabilities using its unreleased Claude Mythos Preview model. The company said initial participants uncovered more than 10,000 high- and critical-severity flaws, prompting the program’s expansion into sectors including healthcare, energy and communications. Anthropic also signaled plans to broaden access to its cybersecurity tools while continuing to develop safeguards designed to prevent misuse of the model’s advanced cyber capabilities.
- In May, Anthropic committed $200 million in grants and Claude-related support to the Gates Foundation, with a focus on advancing healthcare initiatives. The partnership will dedicate resources to accelerating drug and vaccine development and helping governments make better use of health data, particularly in low- and middle-income countries.
- On Jan. 11, Anthropic launched Claude for Healthcare, a HIPAA-compliant version of its AI platform tailored for providers, payers, life sciences organizations and patients. The platform includes tools for prior authorizations, claims appeals, care coordination, regulatory submissions and patient support, while integrating with healthcare data sources such as CMS coverage databases, ICD-10 codes and provider registries. Anthropic also expanded its life sciences offerings to support clinical trial operations and regulatory workflows.
What is this list of Anthropic’s healthcare moves based on?
The list rounds up Anthropic’s major healthcare moves of 2026, including product launches, partnerships, drug discovery work and AI policy proposals, in reverse chronological order rather than ranked.
How many healthcare moves has Anthropic made in 2026?
The list includes six moves, from the Jan. 11 launch of Claude for Healthcare to the June 30 launch of an internal drug discovery program.
When was this list last updated?
Becker’s published the list July 2, 2026, and has not marked any updates since.
What is Claude for Healthcare?
Claude for Healthcare, launched Jan. 11, 2026, is a HIPAA-compliant version of Anthropic’s AI platform for providers, payers, life sciences organizations and patients, with tools for prior authorizations, claims appeals and care coordination.
Who compiles this list?
Becker’s Hospital Review’s Naomi Diaz compiled the list.
What is Anthropic’s biggest financial commitment in healthcare?
In May 2026, Anthropic committed $200 million in grants and Claude-related support to the Gates Foundation for healthcare initiatives, drug and vaccine development, and health data use in low- and middle-income countries.
Cite this: Beckers Healthcare, 2026
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
